title: [RU 486 and sulprostone in pregnancy termination in the 2nd and 3rd trimesters].
abstract: OBJECTIVE
  Describe our experience with the RU 486 (mifepristone) in case of pregnancy termination induced by sulprostone.
  
  
  METHODS
  Prospective non controlled study in the department of Fetal Medicine of the "Institut de Puériculture de Paris". 158 women undergoing termination of pregnancy during the second and third trimester received a single dose of 600 mg of RU 486, 36 hours prior to infusion of 100 micrograms/hour of sulprostone.
  
  
  METHODS
  Delay between sulprostone therapy and diagnosis of labour duration of delivery. Prostaglandin doses used and frequency of secondary effects.
  
  
  RESULTS
  The mean time between sulprostone administration and diagnosis of labour (146.5 +/- 106 minutes) as well delay of delivery (592.2 +/- 504 minutes) corresponded to the results reported in the literature. The primigravid women needed higher doses of prostaglandin and consequently experienced more secondary effects. No severe secondary effects were observed in this study.
  
  
  CONCLUSIONS
  RU 486 is a satisfactory treatment for pregnancy termination during the second or third trimester.
authors.affiliation: Centre de Diagnostic Prénatal, Institut de Puériculture de Paris.
authors.forename: H
authors.initials: H
authors.lastname: Werner
authors.forename: P
authors.initials: P
authors.lastname: Hohlfeld
authors.forename: F
authors.initials: F
authors.lastname: Jacquemard
authors.forename: V
authors.initials: V
authors.lastname: Mirlesse
authors.forename: D
authors.initials: D
authors.lastname: Menez
authors.forename: F
authors.initials: F
authors.lastname: Daffos
mesh_terms: D000020:Abortifacient Agents, Nonsteroidal / Q000627:therapeutic use*; D000032:Abortion, Therapeutic / Q000379:methods*; D000328:Adult; D002985:Clinical Protocols; D015232:Dinoprostone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008875:Middle Aged; D015735:Mifepristone / Q000627:therapeutic use*; D010298:Parity; D011247:Pregnancy; D011262:Pregnancy Trimester, Second; D011263:Pregnancy Trimester, Third; D011446:Prospective Studies; D013997:Time Factors
chemical_list: D000020:Abortifacient Agents, Nonsteroidal; D015735:Mifepristone; C016767:sulprostone; D015232:Dinoprostone
vernacular_title: RU 486 et sulprostone dans le cadre des interruptions médicales de la grossesse aux 2e et 3e trimestres.